Try our beta test site
Trial record 1 of 1 for:    GSK Anti-IL5 MHE 104317 Mepolizumab
Previous Study | Return to List | Next Study

An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES

Expanded access is currently available for this treatment.
Verified March 2017 by GlaxoSmithKline
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00244686
First received: October 25, 2005
Last updated: March 15, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)